ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Mateon Therapeutics · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
platinum resistant ovarian cancer, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 909761
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.